FDA Unveils Risk Strategies For Drug Industry
The U.S. Food and Drug Administration on Wednesday issued the first draft guidance for the pharmaceutical industry on risk evaluation and mitigation strategies that are required for certain drugs and biologics....To view the full article, register now.
Already a subscriber? Click here to view full article